Navigation Links
Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
Date:9/21/2007

re performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. The Company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.

BIOD-G


'/>"/>
SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. to Present VIAject Clinical Progress at the 2007 American Diabetes Association Meeting
2. PromegaExpress Expands Easy Access to Products with New Cabinet
3. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
4. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
5. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
6. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
(Date:3/27/2015)... , March 27, 2015 Concord Medical ... (NYSE: CCM ), a leading specialty hospital ... network of radiotherapy and diagnostic imaging centers in ... signing of a purchase agreement under which Concord ... subsidiary of the Company, agreed to acquire the ...
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
Breaking Medicine Technology:RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... 2012   Reportlinker.com announces that a new ... catalogue: , Innovations in Wound Care ... Introduction ... the broad range of sizes, shapes, stages, ...
... Global Information, Inc. (GII) is pleased to announce a new ... Competitive Landscape and Market Forecasts to 2017" by GlobalData. ... Insulin Delivery Devices Market is Set to Grow at a ... GlobalData estimated the global insulin delivery devices ...
Cached Medicine Technology:Innovations in Wound Care Devices and Dressings 2Innovations in Wound Care Devices and Dressings 3Innovations in Wound Care Devices and Dressings 4Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 2Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 3Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 4
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 ... new method of sustainable health. After 18 years of ... life, including professional UFC contenders, Dr. Jon Petrick is ... summer. , Just some of the immediate benefits of ... and vitality, increased levels of strength of the immune ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s ... the Chesapeake Conference Center in Chesapeake, Virginia. Each year, ... for women in the Hampton Roads region. The 2015 ... Lives. Women grow stronger through sharing their stories and ... year the WWC™ theme is T-talk where we will share ...
(Date:3/28/2015)... Robles, CA (PRWEB) March 28, 2015 ... restoration specialists , this week released a report about ... the symptoms of asthma sufferers, and according to recent ... children. , According to the Environmental Protection Agency, ... develop asthmatic reactions. Breathing in mold may trigger asthma ...
(Date:3/27/2015)... 2015 The Monogamy Method ... Samantha Sanderson and Jason Rogers has just been released ... attention. The commotion surrounding the course's launch has caught ... publish an in-depth review of the new program. , ... in their lives suddenly start pulling away or expressing ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2
... of India greeted the teachers by saying that we have ... the best minds in the country’.// He emphasized that teachers ... in the country. Dr. Kalam preferred a 10 Point oath ... and foremost, I will love teaching. Teaching will be my ...
... heart disease, and other major cardiovascular risk factors, which ... to the new study that has been published today ... the cholesterol-lowering drug of Pfizer further might lower the ... conditions in certain patients. ,The researchers in ...
... help in determining the condition of the human arterial system. ... a new method// , which can help in the prevention ... determining the state of the human arterial system by diffuse ... the inferences for the diagnosis of the condition of the ...
... rheumatoid arthritis (RA), researchers found that drugs delivered into ... of rheumatoid arthritis, at least in arthritic rats.// ... researchers delivered the drug directly into the spinal cord ... the development of RA. The findings of the ...
... it has asked EU health authorities to re-examine data ... The European Committee for Medicinal Products for Human Use ... with pancreatic cancer need new treatment options like Tarceva, ... increase survival and has already been approved for this ...
... diseases like HIV/AIDS, TB, Malaria, Chagas and Sleeping Sickness ... these days.// This increase in drug production is happening ... which cannot afford costly medicines. Researchers say that some ... can access these drugs. ,The report (The New ...
Cached Medicine News:Health News:Teachers are Creators of Enlightened Citizens in the Country- Dr. A.P.J Abdul Kalam 2Health News:Teachers are Creators of Enlightened Citizens in the Country- Dr. A.P.J Abdul Kalam 3Health News:Lipitor Reduces Risk of Major Cardiovascular Events 2Health News:A New System Developed For Studying The Condition Of The Human Arterial System 2Health News:Drugs Delivered Into CNS More Effective In Treating Rheumatoid Arthritis 2Health News:Producing More Drugs For Lethal Diseases Is Not The Answer 2
... TLIF Instruments are designed to facilitate disc ... bone graft during interbody fusion. The TLIF ... easy use during TLIF, for which they ... be used very effectively in PLIF and ...
... has developed a versatile set of ... interbody fusion procedures precise, simple and ... Instrument Set is the ideal complement ... implants and Bacfix Thoracolumbar System. This ...
CD HORIZON SEXTANT Rod Insertion System...
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Medicine Products: